Suklabaidya, S., Das, B., Ali, S. A., Jain, S., Swaminathan, S., Mohanty, A. K., . . . Senapati, S. (2016). Characterization and use of HapT1-derived homologous tumors as a preclinical model to evaluate therapeutic efficacy of drugs against pancreatic tumor desmoplasia. Oncotarget, 7(27), 41825-41842. https://doi.org/10.18632/oncotarget.9729
Chicago Style (17th ed.) CitationSuklabaidya, Sujit, et al. "Characterization and Use of HapT1-derived Homologous Tumors as a Preclinical Model to Evaluate Therapeutic Efficacy of Drugs Against Pancreatic Tumor Desmoplasia." Oncotarget 7, no. 27 (2016): 41825-41842. https://doi.org/10.18632/oncotarget.9729.
MLA (9th ed.) CitationSuklabaidya, Sujit, et al. "Characterization and Use of HapT1-derived Homologous Tumors as a Preclinical Model to Evaluate Therapeutic Efficacy of Drugs Against Pancreatic Tumor Desmoplasia." Oncotarget, vol. 7, no. 27, 2016, pp. 41825-41842, https://doi.org/10.18632/oncotarget.9729.